Incidence of late acute rejection and progression to chronic rejection in pediatric liver recipients

Transplant Proc. 1997 Feb-Mar;29(1-2):428-9. doi: 10.1016/s0041-1345(96)00165-0.

Authors

M Sellers¹, A Singer, E Maller, K Olthoff, D Jacobowski, A Shaked

Affiliation

¹ Department of Surgery, Children's Hospital of Philadelphia, Pennsylvania, USA.

PMID: 9123065
DOI: 10.1016/s0041-1345(96)00165-0

No abstract available

MeSH terms

Acute Disease
Child
Chronic Disease
Cyclosporine / therapeutic use
Follow-Up Studies
Graft Rejection / drug therapy
Graft Rejection / epidemiology*
Humans
Immunosuppressive Agents / therapeutic use
Incidence
Liver Transplantation* / immunology
Liver Transplantation* / physiology
Muromonab-CD3 / therapeutic use
Retrospective Studies
Tacrolimus / therapeutic use
Time Factors
Treatment Refusal

Substances

Immunosuppressive Agents
Muromonab-CD3
Cyclosporine
Tacrolimus